Fintel reports that on April 4, 2025, Oppenheimer downgraded their outlook for RXO (NYSE:RXO) from Outperform to Perform.

Oppenheimer & Co. Inc. purchased a new stake in shares of Fidelity Fundamental Large Cap Core ETF (BATS:FFLC – Free Report) during the 4th quarter, Holdings Channel.com reports.The fund ...

Oppenheimer highlighted Mosaic’s internal ... Mosaic aims to grow beyond its core phosphate and potash markets by expanding into new products, including biologicals, which are expected to ...

The Artificial Intelligence (AI) race needs to slow down and IT firms should instead be focusing on the bigger picture to ...

Oppenheimer initiated coverage on Lam Research Corp (NASDAQ:LRCX) with an Outperform rating and a price target of $95 given the semiconductor equipment maker’s dominant position in etch technology and ...

Christopher Nolan’s Oppenheimer was that rare movie that was both a box office hit and a serious award winner. It also had one of the most incredibly stacked casts in recent memory. Jack Quaid ...

NEW YORK, March 19, 2025 /PRNewswire/ -- GBI, the leading institutional platform for physical precious metals investments, today announced its strategic integration with Oppenheimer & Co. Inc., a ...

Lam, one of the top five wafer fabrication equipment companies, is poised to benefit as NAND enters a large upgrade cycle and DRAM remains a core bottleneck for AI compute. Oppenheimer projects ...

Mosaic aims to grow beyond its core phosphate and potash markets by expanding into new products, including biologicals, which are expected to contribute ~$200 million in EBITDA by 2030 with ...